Allan Coukell is Pew’s senior director for drugs and medical devices, overseeing the initiatives related to drug and medical device innovation and safety, medical conflicts-of-interest, the pharmaceutical supply chain, pharmacy compounding, antibiotics, prescription drug abuse, FDA and specialty drugs, as well as other efforts related to health costs and care delivery.
Prior to joining Pew, he practiced as a clinical pharmacist in oncology at the London Health Sciences Center and Ontario Regional Cancer Center, served as a senior medical writer and editor with the medical journal publisher Adis International, and covered health and science as a reporter and producer for WBUR (NPR) in Boston and Radio New Zealand. He is Vice Chair of the Medical Device Innovation Consortium and a board member of the Reagan Udall Foundation for the FDA. He served previously as consumer representative on the FDA’s Cardiovascular and Renal Drugs Advisory Committee.
Recent WorkView All
"Even in the midst of partisan stalemate, Congress can still come together to pass meaningful legislation to protect the public's health. We applaud Senate passage of the bill and urge President Obama to sign it immediately. Counterfeit and contaminated drugs have taken hundreds of American lives and added hundreds of millions of dollars to our nation's health-care costs. This legislation will... Read More
WASHINGTON — Nearly nine in 10 Americans recognize that antibiotics are effective treatments for fighting bacterial infections like strep throat, but more than a third mistakenly believe the drugs are also appropriate treatments for viral infections such as the common cold. Read More
As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic
WASHINGTON — Prescription painkillers are responsible for more fatal overdoses in the United States than heroin and cocaine combined. And while most states have programs to curb abuse and addiction, a new report from Brandeis University shows that many states do not fully analyze the data they collect. Read More